Single User License
INR 170050
Site License
INR 340100
Corporate User License
INR 510150

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Respiratory Syncytial Virus RSV Infections Global Clinical Trials Review, H1

Respiratory Syncytial Virus RSV Infections Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H1, 2015" provides an overview of Respiratory Syncytial Virus (RSV) Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Respiratory Syncytial Virus (RSV) Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 7

Respiratory Syncytial Virus (RSV) Infections 7

Report Guidance 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Five Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by G7 Countries: Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials 16

Clinical Trials by Phase in G7 Countries 17

Clinical Trials in G7 Countries by Trial Status 18

Clinical Trials by E7 Countries: Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials 19

Clinical Trials by Phase in E7 Countries 20

Clinical Trials in E7 Countries by Trial Status 21

Clinical Trials by Phase 22

In Progress Trials by Phase 23

Clinical Trials by Trial Status 24

Clinical Trials by End Point Status 25

Unaccomplished Trials of Respiratory Syncytial Virus (RSV) Infections 26

Subjects Recruited Over a Period of Time 29

Clinical Trials by Sponsor Type 30

Prominent Sponsors 31

Top Companies Participating in Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials 32

Prominent Drugs 33

Latest Clinical Trials News on Respiratory Syncytial Virus (RSV) Infections 34

Apr 21, 2015: Advanced Inhalation Therapies to Present AIT-RSV Clinical Data at Two Upcoming Medical Meetings 34

Apr 07, 2015: ADMA Biologics Announces Data to be Presented at the Clinical Immunology Society 2015 Annual Meeting 34

Clinical Trial Profiles 35

Clinical Trial Overview of Top Companies 35

AstraZeneca Plc 35

Clinical Trial Overview of AstraZeneca Plc 35

Novavax, Inc. 38

Clinical Trial Overview of Novavax, Inc. 38

Johnson & Johnson 39

Clinical Trial Overview of Johnson & Johnson 39

Gilead Sciences, Inc. 40

Clinical Trial Overview of Gilead Sciences, Inc. 40

GlaxoSmithKline Plc 41

Clinical Trial Overview of GlaxoSmithKline Plc 41

AbbVie Inc. 42

Clinical Trial Overview of AbbVie Inc. 42

Alnylam Pharmaceuticals, Inc. 43

Clinical Trial Overview of Alnylam Pharmaceuticals, Inc. 43

Ablynx NV 44

Clinical Trial Overview of Ablynx NV 44

Abbott Laboratories 45

Clinical Trial Overview of Abbott Laboratories 45

Novartis AG 46

Clinical Trial Overview of Novartis AG 46

Clinical Trial Overview of Top Institutes / Government 47

The National Institute of Allergy and Infectious Diseases 47

Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 47

Fred Hutchinson Cancer Research Center 48

Clinical Trial Overview of Fred Hutchinson Cancer Research Center 48

Rambam Health Care Campus 49

Clinical Trial Overview of Rambam Health Care Campus 49

VU University Medical Center 50

Clinical Trial Overview of VU University Medical Center 50

Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi 51

Clinical Trial Overview of Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi 51

Chinese University of Hong Kong 52

Clinical Trial Overview of Chinese University of Hong Kong 52

Hurley Medical Center 53

Clinical Trial Overview of Hurley Medical Center 53

Memorial Sloan Kettering Cancer Center 54

Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 54

National Institute of Infectious Diseases 55

Clinical Trial Overview of National Institute of Infectious Diseases 55

Netherlands Asthma Foundation 56

Clinical Trial Overview of Netherlands Asthma Foundation 56

Five Key Clinical Profiles 57

Appendix 99

Abbreviations 99

Definitions 99

Research Methodology 100

Secondary Research 100

About GlobalData 101

Contact Us 101

Disclaimer 101

Source 102

List of Figures

Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Region (%), 2015* 8

Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 9

Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 10

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 11

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 12

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 13

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 14

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 15

Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 16

Respiratory Syncytial Virus (RSV) Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17

Respiratory Syncytial Virus (RSV) Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18

Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 19

Respiratory Syncytial Virus (RSV) Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 20

Respiratory Syncytial Virus (RSV) Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 21

Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Phase (%), 2015* 22

Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 23

Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015* 24

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015* 25

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29

Respiratory Syncytial Virus (RSV) Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

GlobalData Methodology 100

List of Tables

Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Region, 2015* 8

Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 9

Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 10

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 11

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 12

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, North America, Top Countries, 2015* 13

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 14

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 15

Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 16

Respiratory Syncytial Virus (RSV) Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17

Respiratory Syncytial Virus (RSV) Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18

Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 19

Respiratory Syncytial Virus (RSV) Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 20

Respiratory Syncytial Virus (RSV) Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 21

Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Phase, 2015* 22

Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 23

Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015* 24

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015* 25

Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Suspended Clinical Trials, 2015* 26

Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Withdrawn Clinical Trials, 2015* 27

Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Terminated Clinical Trials, 2015* 28

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29

Respiratory Syncytial Virus (RSV) Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 35

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Novavax, Inc., 2015* 38

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 39

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2015* 40

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 41

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 42

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Alnylam Pharmaceuticals, Inc., 2015* 43

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Ablynx NV, 2015* 44

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 45

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 46

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 47

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2015* 48

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Rambam Health Care Campus, 2015* 49

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2015* 50

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi, 2015* 51

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015* 52

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Hurley Medical Center, 2015* 53

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 54

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Infectious Diseases, 2015* 55

Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Netherlands Asthma Foundation, 2015* 56

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

AstraZeneca Plc

Novavax, Inc.

Johnson & Johnson

Gilead Sciences, Inc.

GlaxoSmithKline Plc

AbbVie Inc.

Alnylam Pharmaceuticals, Inc.

Ablynx NV

Abbott Laboratories

Novartis AG

Respiratory Syncytial Virus (RSV) Infections Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Respiratory Syncytial Virus (RSV) Infections, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com